首页> 美国卫生研究院文献>Frontiers in Physiology >Current Understanding of the Pathophysiology of Myocardial Fibrosis and Its Quantitative Assessment in Heart Failure
【2h】

Current Understanding of the Pathophysiology of Myocardial Fibrosis and Its Quantitative Assessment in Heart Failure

机译:心力衰竭的心肌纤维化病理生理学及其定量评估的最新认识

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Myocardial fibrosis is an important part of cardiac remodeling that leads to heart failure and death. Myocardial fibrosis results from increased myofibroblast activity and excessive extracellular matrix deposition. Various cells and molecules are involved in this process, providing targets for potential drug therapies. Currently, the main detection methods of myocardial fibrosis rely on serum markers, cardiac magnetic resonance imaging, and endomyocardial biopsy. This review summarizes our current knowledge regarding the pathophysiology, quantitative assessment, and novel therapeutic strategies of myocardial fibrosis.
机译:心肌纤维化是心脏重塑的重要组成部分,可导致心力衰竭和死亡。心肌纤维化是由于成纤维细胞活性增加和细胞外基质沉积过多所致。该过程涉及各种细胞和分子,为潜在的药物治疗提供了靶标。当前,心肌纤维化的主要检测方法依靠血清标志物,心脏磁共振成像和心内膜活检。这篇综述总结了我们目前有关心肌纤维化的病理生理学,定量评估和新颖治疗策略的知识。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号